Loading...

Categories

9 Egypt Hyperglycemics Reports

MEA DPP-4 Inhibitors Market

Country Covered: Egypt

Study Period: 2019- 2029

Major Players: Merck, Novartis, Boehringer Ingelheim, AstraZeneca, Eli Lilly and Company

Middle East And Africa Meglitinide Industry

Country Covered: Egypt

Study Period: 2018 - 2029

Major Players: Novo Nordisk, Glenmark, Kissei, Novartis, Biocon

Middle East and Africa Diabetes Treatment Market

Country Covered: Egypt

Study Period: 2019- 2029

Major Players: Novo Nordisk, Sanofi, Eli lilly, Wockhardt, Pfizer

Meglitinides Market

Country Covered: Egypt

Study Period: 2019- 2029

Major Players: Glenmark Pharmaceuticals, Novartis, Kissei Pharmaceuticals, Biocon, Novo Nordisk A/S

SGLT2 Inhibitors Market

Country Covered: Egypt

Study Period: 2019 - 2029

Major Players: Janssen Pharmaceuticals, Eli Lilly, Bristol Myers Squibb, AstraZeneca Pharmaceuticals, Astellas

Glargine Insulin Market

Country Covered: Egypt

Study Period: 2018 - 2029

Major Players: Sanofi Aventis, Novo Nordisk AS, Biocon, Eli Lilly and Company, Julphar

Basal Insulin (Long-Acting Insulin) Market

Country Covered: Egypt

Study Period: 2019 - 2029

Major Players: Novo Nordisk, Sanofi, Eli Lilly, Biocon, Wockhardt

Sulfonylureas Industry

Country Covered: Egypt

Study Period: 2019- 2029

Major Players: Sanofi Aventis, Pfizer Inc., Merck & Co., Inc., Torrent Pharma, Dr. Reddy's Laboratories

Biguanides Market

Country Covered: Egypt

Study Period: 2018 - 2029

Major Players: Bristol Myers Squibb, Glenmark Pharmaceuticals, Takeda, Sanofi Aventis, Merck and Co.